skip to main content
Language:
Search Limited to: Search Limited to: Resource type Show Results with: Show Results with: Search type Index

Results 1 - 20 of 95,077  for All Library Resources

Results 1 2 3 4 5 next page
Show only
Result Number Material Type Add to My Shelf Action Record Details and Options
1
Stanford Neuromodulation Therapy (SNT): A Double-Blind Randomized Controlled Trial
Material Type:
Article
Add to My Research

Stanford Neuromodulation Therapy (SNT): A Double-Blind Randomized Controlled Trial

The American journal of psychiatry, 2022-02, Vol.179 (2), p.132-141 [Peer Reviewed Journal]

Copyright © 2022 by the American Psychiatric Association 2022 ;Copyright American Psychiatric Association Feb 2022 ;ISSN: 0002-953X ;EISSN: 1535-7228 ;DOI: 10.1176/appi.ajp.2021.20101429 ;PMID: 34711062

Full text available

2
A randomized, placebo-controlled phase 3 trial of the PI3Kδ inhibitor leniolisib for activated PI3Kδ syndrome
Material Type:
Article
Add to My Research

A randomized, placebo-controlled phase 3 trial of the PI3Kδ inhibitor leniolisib for activated PI3Kδ syndrome

Blood, 2023-03, Vol.141 (9), p.971-983 [Peer Reviewed Journal]

2023 The American Society of Hematology ;2023 by The American Society of Hematology. Licensed under Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International (CC BY-NC-ND 4.0), permitting only noncommercial, nonderivative use with attribution. All other rights reserved. ;2023 by The American Society of Hematology. Licensed under Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International (CC BY-NC-ND 4.0), permitting only noncommercial, nonderivative use with attribution. All other rights reserved. 2023 The American Society of Hematology ;ISSN: 0006-4971 ;EISSN: 1528-0020 ;DOI: 10.1182/blood.2022018546 ;PMID: 36399712

Full text available

3
Effect of a single dose of the interleukin-6 receptor antagonist tocilizumab on inflammation and troponin T release in patients with non-ST-elevation myocardial infarction: a double-blind, randomized, placebo-controlled phase 2 trial
Material Type:
Article
Add to My Research

Effect of a single dose of the interleukin-6 receptor antagonist tocilizumab on inflammation and troponin T release in patients with non-ST-elevation myocardial infarction: a double-blind, randomized, placebo-controlled phase 2 trial

European heart journal, 2016-08, Vol.37 (30), p.2406-2413 [Peer Reviewed Journal]

Published on behalf of the European Society of Cardiology. All rights reserved. © The Author 2016. For permissions please email: journals.permissions@oup.com. ;ISSN: 0195-668X ;EISSN: 1522-9645 ;DOI: 10.1093/eurheartj/ehw171 ;PMID: 27161611

Full text available

4
Efficacy and safety of eptinezumab in patients with chronic migraine: PROMISE-2
Material Type:
Article
Add to My Research

Efficacy and safety of eptinezumab in patients with chronic migraine: PROMISE-2

Neurology, 2020-03, Vol.94 (13), p.e1365-e1377 [Peer Reviewed Journal]

2020 American Academy of Neurology ;Copyright © 2020 The Author(s). Published by Wolters Kluwer Health, Inc. on behalf of the American Academy of Neurology. ;Copyright © 2020 The Author(s). Published by Wolters Kluwer Health, Inc. on behalf of the American Academy of Neurology. 2020 American Academy of Neurology ;ISSN: 0028-3878 ;EISSN: 1526-632X ;DOI: 10.1212/WNL.0000000000009169 ;PMID: 32209650

Full text available

5
Randomized, Double-Blind, Placebo-Controlled, Global Phase III Trial of Talimogene Laherparepvec Combined With Pembrolizumab for Advanced Melanoma
Material Type:
Article
Add to My Research

Randomized, Double-Blind, Placebo-Controlled, Global Phase III Trial of Talimogene Laherparepvec Combined With Pembrolizumab for Advanced Melanoma

Journal of clinical oncology, 2023-01, Vol.41 (3), p.528-540 [Peer Reviewed Journal]

2022 by American Society of Clinical Oncology 2022 American Society of Clinical Oncology ;ISSN: 0732-183X ;EISSN: 1527-7755 ;DOI: 10.1200/JCO.22.00343 ;PMID: 35998300

Full text available

6
N-of-1 Trial of a Statin, Placebo, or No Treatment to Assess Side Effects
Material Type:
Article
Add to My Research

N-of-1 Trial of a Statin, Placebo, or No Treatment to Assess Side Effects

The New England journal of medicine, 2020-11, Vol.383 (22), p.2182-2184 [Peer Reviewed Journal]

Copyright © 2020 Massachusetts Medical Society. All rights reserved. ;ISSN: 0028-4793 ;EISSN: 1533-4406 ;DOI: 10.1056/NEJMc2031173 ;PMID: 33196154

Full text available

7
Efficacy and Safety of Sintilimab Plus Pemetrexed and Platinum as First-Line Treatment for Locally Advanced or Metastatic Nonsquamous NSCLC: a Randomized, Double-Blind, Phase 3 Study (Oncology pRogram by InnovENT anti-PD-1-11)
Material Type:
Article
Add to My Research

Efficacy and Safety of Sintilimab Plus Pemetrexed and Platinum as First-Line Treatment for Locally Advanced or Metastatic Nonsquamous NSCLC: a Randomized, Double-Blind, Phase 3 Study (Oncology pRogram by InnovENT anti-PD-1-11)

Journal of thoracic oncology, 2020-10, Vol.15 (10), p.1636-1646 [Peer Reviewed Journal]

2020 International Association for the Study of Lung Cancer ;Copyright © 2020 by the International Association for the Study of Lung Cancer ;Copyright © 2020 International Association for the Study of Lung Cancer. Published by Elsevier Inc. All rights reserved. ;ISSN: 1556-0864 ;EISSN: 1556-1380 ;DOI: 10.1016/j.jtho.2020.07.014 ;PMID: 32781263

Full text available

8
Hydroxychloroquine in Nonhospitalized Adults With Early COVID-19: A Randomized Trial
Material Type:
Article
Add to My Research

Hydroxychloroquine in Nonhospitalized Adults With Early COVID-19: A Randomized Trial

Annals of Internal Medicine, 2020-10 [Peer Reviewed Journal]

2020. Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the associated terms available at https://annals.org/aim/pages/conditions-of-use ;DOI: 10.7326/M20-4207

Digital Resources/Online E-Resources

9
Rindopepimut with Bevacizumab for Patients with Relapsed EGFRvIII-Expressing Glioblastoma (ReACT): Results of a Double-Blind Randomized Phase II Trial
Material Type:
Article
Add to My Research

Rindopepimut with Bevacizumab for Patients with Relapsed EGFRvIII-Expressing Glioblastoma (ReACT): Results of a Double-Blind Randomized Phase II Trial

Clinical cancer research, 2020-04, Vol.26 (7), p.1586-1594 [Peer Reviewed Journal]

2020 American Association for Cancer Research. ;ISSN: 1078-0432 ;EISSN: 1557-3265 ;DOI: 10.1158/1078-0432.CCR-18-1140 ;PMID: 32034072

Full text available

10
Allogenic Fecal Microbiota Transplantation in Patients With Nonalcoholic Fatty Liver Disease Improves Abnormal Small Intestinal Permeability: A Randomized Control Trial
Material Type:
Article
Add to My Research

Allogenic Fecal Microbiota Transplantation in Patients With Nonalcoholic Fatty Liver Disease Improves Abnormal Small Intestinal Permeability: A Randomized Control Trial

The American journal of gastroenterology, 2020-07, Vol.115 (7), p.1055 [Peer Reviewed Journal]

EISSN: 1572-0241 ;DOI: 10.14309/ajg.0000000000000661 ;PMID: 32618656

Full text available

11
Olaparib tablets as maintenance therapy in patients with platinum-sensitive, relapsed ovarian cancer and a BRCA1/2 mutation (SOLO2/ENGOT-Ov21): a double-blind, randomised, placebo-controlled, phase 3 trial
Material Type:
Article
Add to My Research

Olaparib tablets as maintenance therapy in patients with platinum-sensitive, relapsed ovarian cancer and a BRCA1/2 mutation (SOLO2/ENGOT-Ov21): a double-blind, randomised, placebo-controlled, phase 3 trial

The lancet oncology, 2017-09, Vol.18 (9), p.1274-1284 [Peer Reviewed Journal]

2017 Elsevier Ltd ;Copyright © 2017 Elsevier Ltd. All rights reserved. ;Copyright Elsevier Limited Sep 1, 2017 ;ISSN: 1470-2045 ;EISSN: 1474-5488 ;DOI: 10.1016/S1470-2045(17)30469-2 ;PMID: 28754483

Full text available

12
Risankizumab as maintenance therapy for moderately to severely active Crohn's disease: results from the multicentre, randomised, double-blind, placebo-controlled, withdrawal phase 3 FORTIFY maintenance trial
Material Type:
Article
Add to My Research

Risankizumab as maintenance therapy for moderately to severely active Crohn's disease: results from the multicentre, randomised, double-blind, placebo-controlled, withdrawal phase 3 FORTIFY maintenance trial

intranet 671955 ;ISSN: 1474-547X ;ISSN: 0140-6736 ;EISSN: 1474-547X ;DOI: 10.1016/S0140-6736(22)00466-4

Full text available

13
Nintedanib in Progressive Fibrosing Interstitial Lung Diseases
Material Type:
Article
Add to My Research

Nintedanib in Progressive Fibrosing Interstitial Lung Diseases

The New England journal of medicine, 2019-10, Vol.381 (18), p.1718-1727 [Peer Reviewed Journal]

Copyright © 2019 Massachusetts Medical Society. All rights reserved. ;Copyright © 2019 Massachusetts Medical Society. ;ISSN: 0028-4793 ;EISSN: 1533-4406 ;DOI: 10.1056/NEJMoa1908681 ;PMID: 31566307

Full text available

14
MONARCH 3: Abemaciclib As Initial Therapy for Advanced Breast Cancer
Material Type:
Article
Add to My Research

MONARCH 3: Abemaciclib As Initial Therapy for Advanced Breast Cancer

Journal of clinical oncology, 2017-11, Vol.35 (32), p.3638-3646 [Peer Reviewed Journal]

ISSN: 0732-183X ;EISSN: 1527-7755 ;DOI: 10.1200/jco.2017.75.6155 ;PMID: 28968163

Full text available

15
Mosaic human preimplantation embryos and their developmental potential in a prospective, non-selection clinical trial
Material Type:
Article
Add to My Research

Mosaic human preimplantation embryos and their developmental potential in a prospective, non-selection clinical trial

American journal of human genetics, 2021-12, Vol.108 (12), p.2238-2247 [Peer Reviewed Journal]

2021 The Author(s) ;Copyright © 2021 The Author(s). Published by Elsevier Inc. All rights reserved. ;2021 The Author(s) 2021 ;ISSN: 0002-9297 ;EISSN: 1537-6605 ;DOI: 10.1016/j.ajhg.2021.11.002 ;PMID: 34798051

Full text available

16
Safety and efficacy of the ChAdOx1 nCoV-19 vaccine (AZD1222) against SARS-CoV-2: an interim analysis of four randomised controlled trials in Brazil, South Africa, and the UK
Material Type:
Article
Add to My Research

Safety and efficacy of the ChAdOx1 nCoV-19 vaccine (AZD1222) against SARS-CoV-2: an interim analysis of four randomised controlled trials in Brazil, South Africa, and the UK

The Lancet (British edition), 2021-01, Vol.397 (10269), p.99-111 [Peer Reviewed Journal]

2021 The Author(s). Published by Elsevier Ltd. This is an Open Access article under the CC BY 4.0 license ;Copyright © 2021 The Author(s). Published by Elsevier Ltd. This is an Open Access article under the CC BY 4.0 license. Published by Elsevier Ltd.. All rights reserved. ;2021. The Author(s). Published by Elsevier Ltd. This is an Open Access article under the CC BY 4.0 license. This work is published under https://creativecommons.org/licenses/by/3.0/ (theLicense”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;2021 The Author(s). Published by Elsevier Ltd. This is an Open Access article under the CC BY 4.0 license 2021 ;ISSN: 0140-6736 ;EISSN: 1474-547X ;DOI: 10.1016/S0140-6736(20)32661-1 ;PMID: 33306989

Full text available

17
Molnupiravir for Oral Treatment of Covid-19 in Nonhospitalized Patients
Material Type:
Article
Add to My Research

Molnupiravir for Oral Treatment of Covid-19 in Nonhospitalized Patients

New England Journal of Medicine, 2022-02, Vol.386 (6), p.509-520 [Peer Reviewed Journal]

Copyright © 2021 Massachusetts Medical Society. All rights reserved. ;Copyright © 2021 Massachusetts Medical Society. ;2021. Not withstanding the ProQuest Terms and Conditions, you may use this content in accordance with the associated terms available at https://www.nejm.org/about-nejm/permissions?query=footer ;ISSN: 0028-4793 ;EISSN: 1533-4406 ;DOI: 10.1056/NEJMoa2116044 ;PMID: 34914868

Digital Resources/Online E-Resources

18
Trial of Anifrolumab in Active Systemic Lupus Erythematosus
Material Type:
Article
Add to My Research

Trial of Anifrolumab in Active Systemic Lupus Erythematosus

The New England journal of medicine, 2020-01, Vol.382 (3), p.211-221 [Peer Reviewed Journal]

Copyright © 2019 Massachusetts Medical Society. All rights reserved. ;Copyright © 2019 Massachusetts Medical Society. ;ISSN: 0028-4793 ;EISSN: 1533-4406 ;DOI: 10.1056/NEJMoa1912196 ;PMID: 31851795

Full text available

19
Comparison of protocols and registry entries to published reports for randomised controlled trials
Material Type:
Article
Add to My Research

Comparison of protocols and registry entries to published reports for randomised controlled trials

Cochrane database of systematic reviews, 2011-01, Vol.2011 (1), p.MR000031-MR000031 [Peer Reviewed Journal]

Copyright © 2011 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd. ;EISSN: 1465-1858 ;EISSN: 1469-493X ;DOI: 10.1002/14651858.MR000031.pub2 ;PMID: 21249714

Full text available

20
Cardiovascular and kidney outcomes with finerenone in patients with type 2 diabetes and chronic kidney disease: the FIDELITY pooled analysis
Material Type:
Article
Add to My Research

Cardiovascular and kidney outcomes with finerenone in patients with type 2 diabetes and chronic kidney disease: the FIDELITY pooled analysis

European heart journal, 2022-02, Vol.43 (6), p.474-484 [Peer Reviewed Journal]

The Author(s) 2021. Published by Oxford University Press on behalf of the European Society of Cardiology. 2021 ;The Author(s) 2021. Published by Oxford University Press on behalf of the European Society of Cardiology. ;The Author(s) 2021. Published by Oxford University Press on behalf of the European Society of Cardiology. 2021 ;ISSN: 0195-668X ;EISSN: 1522-9645 ;DOI: 10.1093/eurheartj/ehab777 ;PMID: 35023547

Full text available

Results 1 - 20 of 95,077  for All Library Resources

Results 1 2 3 4 5 next page

Personalize your results

  1. Edit

Refine Search Results

Expand My Results

  1.   

Show only

  1. Peer-reviewed Journals (90,315)

Refine My Results

Creation Date 

From To
  1. Before 1968  (157)
  2. 1968 To 1984  (5,235)
  3. 1985 To 1997  (20,602)
  4. 1998 To 2011  (38,023)
  5. After 2011  (31,060)
  6. More options open sub menu

Subject 

  1. Double-Blind Method  (95,050)
  2. Humans  (94,098)
  3. Science & Technology  (80,972)
  4. Life Sciences & Biomedicine  (79,846)
  5. Male  (70,281)
  6. Female  (69,822)
  7. Adult  (54,794)
  8. Middle Aged  (51,468)
  9. Biological And Medical Sciences  (39,044)
  10. Medical Sciences  (36,627)
  11. Aged  (32,814)
  12. Treatment Outcome  (24,037)
  13. Pharmacology. Drug Treatments  (20,637)
  14. Adolescent  (17,299)
  15. Prospective Studies  (12,508)
  16. Pharmacology & Pharmacy  (11,559)
  17. Cross-Over Studies  (10,648)
  18. Young Adult  (10,263)
  19. Clinical Trials  (10,065)
  20. Time Factors  (9,869)
  21. More options open sub menu

Language 

  1. English  (93,911)
  2. Japanese  (11,890)
  3. Portuguese  (560)
  4. German  (425)
  5. Spanish  (370)
  6. French  (284)
  7. Russian  (88)
  8. Norwegian  (62)
  9. Italian  (39)
  10. Chinese  (38)
  11. Polish  (23)
  12. Turkish  (18)
  13. Korean  (13)
  14. Swedish  (13)
  15. Dutch  (8)
  16. Croatian  (6)
  17. Serbian  (4)
  18. Czech  (3)
  19. Persian  (3)
  20. Afrikaans  (2)
  21. More options open sub menu

Searching Remote Databases, Please Wait